Medical & Scientific Advisory Workspace
A medical advisory board platform for pharma and medtech that enables continuous, compliant expert collaboration — with structured insight capture, institutional contracting, and lifecycle intelligence.
Run medical and scientific advisory boards in a continuous, compliant environment — with structured insight capture, institutional contracting, FMV control, and full lifecycle traceability.
Structured, compliant expert input for real decisions.
Discuss Your Advisory Use Case
WHO THIS IS FOR
Built for Medical Affairs and Clinical Leadership
Designed for Medical Affairs, Clinical Strategy, and Regulatory teams responsible for structured, compliant expert engagement.
Not early-stage exploration.
Decision validation.
R&D collaboration explores direction.
Advisory formalizes decisions.
THE CHALLENGE
Advisory execution is fragmented and inefficient
Advisory still runs on a fragmented stack.
Email for coordination. Meetings for discussion.
Separate tools for contracts, FMV, documents, and reporting.
In practice, teams rely on spreadsheets and disconnected workflows to manage experts, approvals, and outputs.
That fragmentation is not visible during the meeting — but it drives most of the inefficiency around it.
Execution becomes heavy and difficult to scale.
Preparation is inconsistent.
Administrative effort grows.
Insights are lost.
Compliance risk increases.
Advisory becomes slower, more expensive, and harder to operate — while the value of expert input remains underutilized.
THE STRUCTURAL LIMITATION
Why this keeps happening
Advisory does not break during the meeting.
It breaks around it.
Onboarding, pre-read, input, follow-up, contracting, and payment remain disconnected.
That is where advisory breaks.
THE SOLUTION
A structured advisory infrastructure
Meplis turns advisory from isolated meetings into a continuous, structured workspace.
Meplis provides a medical advisory board platform for pharma and medtech that structures expert interaction into a continuous, compliant workflow.
Experts are identity-verified.
Interactions are structured.
Insights remain connected.
Participation and compensation are traceable.
This is not another advisory tool.
It is a controlled expert decision environment.
HOW IT WORKS
Advisory is a sequence
Advisory is not just discussion.
It is a sequence.
Onboarding. Pre-read. Input. Meeting. Follow-up. Payment.
If that sequence breaks, advisory breaks.
Meplis structures and connects every step.
EXECUTION MODELS
Execution in practice
Before, during, and after the meeting
Contracting and FMV — where advisory actually breaks
Meplis embeds contracting, approvals, signatures, and FMV directly into the workflow.
EXECUTION MODELS CONTINUED
Two advisory modes
Run a single advisory board when needed.
Or maintain a persistent expert board over time.
Advisory becomes continuous instead of episodic.
Insight builds instead of resetting.
FROM GAPS TO OPPORTUNITIES
From participation to medical intelligence
As a medical advisory board platform for pharma and medtech, Meplis ensures that expert input is captured, structured, and reused across decisions.
Advisory output is usually lost in summaries, notes, and recordings.
Meplis captures input in structure.
What was discussed.
Who contributed.
Where consensus formed.
Where opinions diverged.
Insight becomes reusable across teams, decisions, and time
WHY THIS APPROACH IS DIFFERENT
Insight becomes signal
The output is not the meeting.
It is the signal within expert input.
What experts agree on.
Where opinions diverge.
Which topics repeat.
What gains traction over time.
Not just what was said.
But what it means.
COMPLIANCE
Compliance and transparency
Built for regulated expert collaboration:
- verified HCP identity
- NDA and disclosure control
- FMV tracking
- payment workflow support
- audit-ready interaction logs
Compliance is not added around the process.
It is built into it.
EXECUTION FLOW
Continuous evidence loop
Post-market evidence does not follow a fixed sequence.
Data is captured, monitored, validated, and acted on as it evolves.
There is no defined start or end point — only continuous progression.
Each interaction contributes to the next.
Each signal feeds further analysis.
Each insight informs immediate action.
Evidence is not processed in steps.
It compounds over time.
REAL INTELLIGENCE LAYER
From expert input to decision infrastructure
Advisory insights are structured into a reusable decision layer.
Teams see what is changing, where expert opinion aligns, and what requires action.
Not more reports.
Better decisions from connected expert input.
CLOSING THE LIFECYLE LOOP
Expert input that keeps working
Advisory should not end in a report.
Expert input informs:
R&D direction
Clinical strategy
Post-market interpretation
Medical and commercial execution
One interaction.
Multiple decisions.
One connected lifecycle.
INTEGRATION
Works with your existing systems
Meplis connects to the tools advisory teams already use for meetings, documents, compliance workflows, and payments.
It does not replace your stack.
It connects it into one structured advisory system.
As a medical advisory board platform for pharma and medtech, Meplis connects existing systems into one structured advisory environment.
START SMALL
Start with a focused board
Begin with one advisory board, a defined expert group, and one clear objective.
Validate workflow, compliance, and insight capture in a controlled scope.
Then scale across brands, indications, and lifecycle stages.
Turn advisory into structured medical intelligence
Move beyond fragmented meetings, heavy administration, and lost expert input.
Discuss Your Use Case
Frequently Asked Questions
A: Those tools support meetings. Meplis structures the full advisory workflow — from onboarding and pre-input to contracting, FMV, and insight reuse — in one connected environment.
A: No. It improves how advisory boards are executed, captured, and reused.
A: Because contracting and institutional approval are the main sources of delay and complexity. Meplis treats them as part of the workflow, not an external step.
A: Participation and contribution can be linked directly to FMV and payment workflows, with full traceability and audit-ready records.
A: They are captured in structure — including consensus, disagreement, and recurring themes — and remain reusable across future decisions.
A: Yes. Meplis connects to existing tools for meetings, documents, compliance workflows, and payments.
A: A focused start is possible with one advisory board, a defined expert group, and a clear objective.
A: R&D collaboration explores direction and early ideas. Advisory is structured, sequenced, and compliance-driven — focused on validating decisions.